Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: A five-year, randomized, double-masked, clinical trial

Research output: Contribution to journalArticlepeer-review

24 Scopus citations
Original languageEnglish
Pages (from-to)598-618
Number of pages21
JournalTransactions of the American Ophthalmological Society
Volume87
StatePublished - Dec 1 1989

Cite this